1 week ago Gold Resource Corporation Reports Financial Results for 2024 Year End

DENVER — Gold Resource Corporation (NYSE American: GORO) (the “Company”) is pleased to announce its year end operational results from its Don David Gold Mine (“DDGM”) near Oaxaca, Mexico. “Although the 2024 mine plan was based on lower grade ore, our aging mining fleet resulted in less tonnes mined and reduced our ability to access […]

Other

3 w. ago Brookfield Business Corporation Completes 2024 Annual Filings

BROOKFIELD, NEWS, March 31, 2025 (GLOBE NEWSWIRE) — Brookfield Business Corporation (NYSE, TSX: BBUC) today announced that it has filed its 2024 annual report on Form 20-F, including its audited financial statements for the year ended December 31, 2024, with the SEC on EDGAR as well as with the Canadian securities authorities on SEDAR+. These […]

Economics

3 w. ago Firm Capital Mortgage Investment Corporation Announces Q4/2024 Results

TORONTO, March 31, 2025 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX FC, FC.DB.I, FC.DB.J ,FC.DB. K and FC.DB.L) today released its financial statements for the three and twelve months ended December 31, 2024. NET INCOME For the three months ended December 31, 2024, net income increased by 9.9% to $9,164,362 as […]

Economics

3 w. ago Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2024 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue of Junshi Biosciences was […]

Other

3 w. ago Aptose Reports Year End 2024 Results and Corporate Highlights

Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third Drug to Include in AML Triplet Therapy Aptose Signs Debt Conversion Agreement with Hanmi SAN DIEGO and TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), […]

Other

3 w. ago Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 2025 Reviewing pipeline and development plans for HBV programs Continued focus on efficient deployment of financial resources and personnel – terminated ATM program and implemented reduction of workforce by 57% […]

Culture

4 w. ago Urbana Corporation Has Filed Audited 2024 Annual Financial Statements

/NOT FOR DISTRIBUTION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE U.S./ TORONTO, March 24, 2025 (GLOBE NEWSWIRE) — Urbana Corporation (TSX & CSE: URB & URB.A) Urbana Corporation announces today that it has filed its audited Financial Statements and Management’s Discussion and Analysis for the year ended December 31, 2024 with the applicable […]

Other

4 w. ago Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st

SHANGHAI, March 23, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (“NMPA”) has approved the supplemental new drug application (“sNDA”) for the company’s product, toripalimab, in […]

Other